Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

References for PMC Articles for PubMed (Select 23130155)

1.

Addition of inflammatory biomarkers did not improve diabetes prediction in the community: the framingham heart study.

Dallmeier D, Larson MG, Wang N, Fontes JD, Benjamin EJ, Fox CS.

J Am Heart Assoc. 2012 Aug;1(4):e000869. doi: 10.1161/JAHA.112.000869. Epub 2012 Aug 24.

2.

Assessing the Incremental Role of Novel and Emerging Risk Factors.

Cook NR.

Curr Cardiovasc Risk Rep. 2010 Mar 1;4(2):112-119.

3.

Thirty-one novel biomarkers as predictors for clinically incident diabetes.

Salomaa V, Havulinna A, Saarela O, Zeller T, Jousilahti P, Jula A, Muenzel T, Aromaa A, Evans A, Kuulasmaa K, Blankenberg S.

PLoS One. 2010 Apr 9;5(4):e10100. doi: 10.1371/journal.pone.0010100.

4.

Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).

Bertoni AG, Burke GL, Owusu JA, Carnethon MR, Vaidya D, Barr RG, Jenny NS, Ouyang P, Rotter JI.

Diabetes Care. 2010 Apr;33(4):804-10. doi: 10.2337/dc09-1679. Epub 2010 Jan 22.

5.

Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications.

Goldberg RB.

J Clin Endocrinol Metab. 2009 Sep;94(9):3171-82. doi: 10.1210/jc.2008-2534. Epub 2009 Jun 9. Review.

PMID:
19509100
6.

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr.

Arch Intern Med. 2007 May 28;167(10):1068-74.

PMID:
17533210
7.

An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes.

Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig M, Pfeiffer AF, Spranger J, Thamer C, Häring HU, Fritsche A, Joost HG.

Diabetes Care. 2007 Mar;30(3):510-5.

PMID:
17327313
8.

Inflammation and insulin resistance.

Shoelson SE, Lee J, Goldfine AB.

J Clin Invest. 2006 Jul;116(7):1793-801. Review. Erratum in: J Clin Invest. 2006 Aug;116(8):2308.

9.

Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.

Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C.

Diabetes. 2005 Oct;54(10):2932-8.

10.

Inflammation and the etiology of type 2 diabetes.

Sjöholm A, Nyström T.

Diabetes Metab Res Rev. 2006 Jan-Feb;22(1):4-10. Review.

PMID:
15991254
11.

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P.

Am J Epidemiol. 2004 May 1;159(9):882-90. Review.

12.

Inflammatory markers and risk of developing type 2 diabetes in women.

Hu FB, Meigs JB, Li TY, Rifai N, Manson JE.

Diabetes. 2004 Mar;53(3):693-700.

13.

Epidemiological approaches to heart disease: the Framingham Study.

DAWBER TR, MEADORS GF, MOORE FE Jr.

Am J Public Health Nations Health. 1951 Mar;41(3):279-81. No abstract available.

14.

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H.

J Clin Invest. 2003 Dec;112(12):1821-30.

15.

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study.

Diabetes. 2003 Jul;52(7):1799-805.

16.

The diabetes risk score: a practical tool to predict type 2 diabetes risk.

Lindström J, Tuomilehto J.

Diabetes Care. 2003 Mar;26(3):725-31.

PMID:
12610029
17.
18.

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M, Koenig W.

Arch Intern Med. 2003 Jan 13;163(1):93-9.

PMID:
12523922
19.

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM.

Diabetes Care. 2002 Nov;25(11):2016-21.

PMID:
12401749
20.

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N; West of Scotland Coronary Prevention Study.

Diabetes. 2002 May;51(5):1596-600.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk